Results 141 to 150 of about 1,137,377 (219)
Enhancing intelligence source performance management through two-stage stochastic programming and machine learning techniques. [PDF]
Wekesa LW, Korir S.
europepmc +1 more source
Integrating Key Nursing Measures into a Comprehensive Healthcare Performance Management System: A Tuscan Experience. [PDF]
Barchielli C, Rafferty AM, Vainieri M.
europepmc +1 more source
Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li +10 more
wiley +1 more source
Health technology assessment (HTA) and performance management (PM): a scoping review on the intersecting realms. [PDF]
Akinbobola EO +3 more
europepmc +1 more source
Performance management in complex adaptive systems: a conceptual framework for health systems. [PDF]
Newton-Lewis T, Munar W, Chanturidze T.
europepmc +1 more source
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source
Professional nurses' perspectives of an ideal performance management process. [PDF]
Ndlovu S, van Wyk NC, Leech R.
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Toward a sustainability performance management framework. [PDF]
Kantabutra S.
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source

